SP
Stonebrook Private Portfolio holdings
AUM
$463M
1-Year Est. Return
18.98%
1 Year Est. Return
+18.98%
AUM
$463M
AUM Growth
+$35.5M
(+8.3%)
Holding
215
Top Buys
| 1 | +$8.83M | |
| 2 | +$4.32M | |
| 3 | +$3.38M | |
| 4 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$3.03M |
| 5 |
Analog Devices
ADI
|
+$2.03M |
Top Sells
| 1 | +$8.76M | |
| 2 | +$6.95M | |
| 3 | +$5.11M | |
| 4 |
Broadcom
AVGO
|
+$1.9M |
| 5 |
MMD
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
|
+$895K |
Sector Composition
| 1 | Technology | 19.63% |
| 2 | Financials | 6.68% |
| 3 | Industrials | 6% |
| 4 | Consumer Discretionary | 5.82% |
| 5 | Healthcare | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Pfizer
PFE
$147B
| $204K | 0.04% |
8,015
-1,638
|
|
||
202
Applied Materials
AMAT
$257B
| $201K | 0.04% |
+982
|
|
||
203
Ford
F
$55.1B
| $175K | 0.04% |
14,635
-14,182
|
|
||
|
CHY
204
Calamos Convertible and High Income Fund
CHY
$935M
| $116K | 0.03% |
10,319
+276
|
|
||
|
IAUX
205
i-80 Gold Corp
IAUX
$1.27B
| $68.2K | 0.01% |
71,353
+9,616
|
|
||
206
Compass Therapeutics
CMPX
$1.01B
| $35.8K | 0.01% |
10,230
-366
|
|
||
207
SES AI
SES
$800M
| $17.1K | ﹤0.01% |
10,263
-215
|
|
||
208
Ironwood Pharmaceuticals
IRWD
$719M
| $14.4K | ﹤0.01% |
+10,985
|
|
||
209
Ring Energy
REI
$201M
| – | – |
-10,881
|
|
||
210
Vertex Pharmaceuticals
VRTX
$111B
| – | – |
-532
|
|
||
211
Zoetis
ZTS
$55.3B
| – | – |
-1,513
|
|
||
212
Aon
AON
$73.9B
| – | – |
-621
|
|
||
213
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7B
| – | – |
-13,705
|
|
||
214
Mondelez International
MDLZ
$74.2B
| – | – |
-3,685
|
|
||
|
MMD
215
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$286M
| – | – |
-60,492
|
|